These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4655879

  • 1. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA, Belousov IuB, Martynov AI, Koroleva SA, Zimin VS.
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H, Norden K, Heinemann L, Stepanauskas M, Schmidt H.
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pyridinol-carbamate and atherosclerosis. Clinical observations and animal experimentation].
    de Oliveira JM.
    Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5310119
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978 Sep; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 12. [Use of vazaprostan in the treatment of multifocal peripheral obliterating lesions of arteries of the lower limbs].
    Driuk NF, Mishalov VG, Pavlichenko LN.
    Klin Khir (1962); 1994 Sep; (10):26-8. PubMed ID: 7602901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Pyridinol-carbamate and atherosclerosis. Clinical studies and animal experiments].
    de Oliveira JM.
    Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5303765
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA, Gorin VV, Shingireĭ MV, Kliuchnikova ZhI, Diukov IV.
    Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of Magnesium compositum in arteriosclerosis of the vessels of the heart, brain and lower extremities].
    Savenkov PM, Martynov AI, Kertsman GI, Bobrovskaia OB, Pogorel'skiĭ AI.
    Kardiologiia; 1971 Oct; 11(10):85-91. PubMed ID: 5138051
    [No Abstract] [Full Text] [Related]

  • 20. [Distribution of obliterating atherosclerosis of the arteries of the lower extremities and its relationship to ischemic heart disease].
    Dokuchaeva EA.
    Kardiologiia; 1974 Feb; 14(2):131-6. PubMed ID: 4825006
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.